Instalab
logoInstalab

Tuna (Thu a 1) IgE

Blood Test
See whether your immune system has flagged tuna as a threat, even when whole-fish allergy tests look unclear.
4.9 (4,236 reviews)
Tested by Diagnostic Solutions Lab
Physician-reviewed results
Results in under 1 week
How it works
Order from Instalab
No prescription or your own doctor's order needed
Get blood drawn
At home
Get results
Explained with clear next steps, no medical jargon

Should you take a Tuna (Thu a 1) IgE test?

This test is most useful if any of these apply to you.

Reacted to Some Fish but Not Others
This test helps clarify which specific fish protein your immune system targets and whether tuna is likely safe for you.
Sensitized on a Standard Fish Panel
If your routine fish allergy test came back positive but you eat fish without symptoms, this test refines what your immune system is actually reacting to.
Reintroducing Fish After Avoidance
If you have avoided fish for years and want to know whether tuna is a safer place to start, component testing can help guide that decision with your allergist.
Parents of Fish-Allergic Children
Fish allergy in children can shift over time, and component testing can show whether tuna may be a tolerable option within a broader fish-allergic profile.

About Tuna (Thu a 1) IgE

If you have ever had an unexplained reaction after eating fish, or you tolerate some fish but not others, this test offers a more precise look at what your immune system is actually responding to. Rather than reading your reaction to a whole tuna extract, it measures whether your body has built antibodies against a specific tuna protein.

Tuna is unusual among fish because it tends to be lower in the main fish allergen, parvalbumin, which is why some people allergic to cod or salmon can still eat tuna safely. A targeted tuna test can help clarify where you actually stand.

What This Test Measures

Thu a 1 IgE (tuna parvalbumin immunoglobulin E) measures the level of a specific antibody in your blood that targets a tuna protein. IgE is the antibody class your immune system uses to flag potential allergens. When IgE binds to a food protein and then attaches to immune cells called mast cells and basophils, re-exposure to that protein can trigger a rapid allergic reaction, including hives, gut symptoms, breathing trouble, or in severe cases anaphylaxis.

The antibody itself is made by plasma cells, a kind of mature B cell, with help from a specialized T cell type that releases signaling molecules driving the immune system toward an allergic response. A positive result means your body has produced antibodies against tuna protein, a state called sensitization. Sensitization is not the same as having allergic symptoms, but it reflects the capacity for an IgE-driven reaction.

Why Tuna Is a Special Case Among Fish

The dominant allergen across most fish species is a small muscle protein called beta-parvalbumin, and people allergic to one fish are often reactive to several others because these proteins look similar across species. Tuna sits at the lower end of this allergen ladder. Quantitative studies show that tuna has markedly lower parvalbumin content than most commonly eaten fish such as cod, carp, herring, and redfish, and large migratory fish like tuna show very low IgE reactivity. A recent fish allergenicity ladder placed tuna in the least allergenic group alongside halibut, salmon, and cod.

A negative IgE result for tuna parvalbumin is informative, though in multinational testing the strongest single predictor of negativity to additional bony fish parvalbumins was mackerel rather than tuna. Even so, a meaningful share of fish-allergic patients may safely tolerate at least one bony fish based on parvalbumin profiling, which is why component testing for tuna can change real decisions about what you eat.

Why the Specific Component Matters

Standard fish allergy testing typically uses whole tuna extract, which contains many proteins mixed together. A whole-extract test can register positive because of cross-reactivity with proteins shared across fish species, even when you do not actually react to tuna. Component testing isolates the specific tuna protein and asks a more focused question: has your immune system produced antibodies against this particular molecule?

In one study of adult fish-allergic patients, IgE to whole fish extracts did not reliably predict allergy to specific fish species. Component-resolved testing, including for parvalbumin, was needed to clarify which fish each person actually reacted to.

Reactions and Anaphylaxis Risk

A positive Thu a 1 IgE result indicates sensitization, but the level alone does not predict how severe a reaction would be. Reaction severity in food allergy depends on many factors beyond IgE, including the cells and signaling molecules involved. A meta-analysis of severe food allergic reactions identified prior anaphylaxis, asthma, and IgE sensitization as risk markers, but none reliably predict who will have the worst reactions.

In one case series, a child with isolated tuna anaphylaxis had a main IgE band at a 40 kDa protein, not the typical parvalbumin band most other fish-allergic patients react to. This is a reminder that tuna allergy can occur through more than one protein, and a negative parvalbumin component does not entirely rule out tuna reactivity.

Cross-Reactivity Beyond Fish

Fish parvalbumin can cross-react with parvalbumins from other animals. Studies have shown IgE cross-reactivity between fish and frog (with 11 of 12 fish-allergic sera reacting to frog beta-parvalbumin), fish and chicken meat (the so-called fish-chicken syndrome), and most recently fish and crocodile, where beta-parvalbumin from crocodile was identified as a major allergen for fish-allergic patients, with roughly 70 percent of fish parvalbumin-sensitized patients showing IgE binding to crocodile parvalbumin. If your tuna parvalbumin IgE is positive, this expands the conversation beyond tuna alone and may influence advice about other exotic meats.

How Food Processing Changes Reactivity

Cooking and canning can substantially change fish allergen behavior. In an older study of highly atopic patients, all 45 challenges with canned tuna were negative, and laboratory analysis showed striking loss of protein fractions and minimal IgE binding compared with cooked tuna. However, more recent data complicates this picture: in a 2023 study, about two-thirds of fish-allergic patients still showed IgE binding to canned fish proteins, and the authors concluded that canned fish may not be safe for all fish-allergic patients. Canned tuna does appear to be among the lower-risk canned fish products, but it should not be assumed safe without medical guidance.

Tracking Your Trend

A single IgE reading is a snapshot, not a verdict. Allergen-specific IgE levels can shift over time, especially in children, and the pattern of change matters as much as the absolute number. Testing once gives you a baseline. Retesting at intervals shows whether sensitization is growing, stable, or fading.

This is especially relevant if you are doing supervised reintroduction of fish, undergoing allergy immunotherapy, or watching for natural resolution. During effective immunotherapy, specific IgE may initially rise, then decline over months to years as tolerance develops. There are no formal guideline-defined intervals for fish-specific IgE monitoring, but a reasonable approach in clinical practice is a baseline now, a follow-up at roughly 6 to 12 months if you are actively making dietary changes or undergoing therapy, and periodic rechecks every 1 to 2 years thereafter, with timing individualized by your allergist.

When Results Can Be Misleading

Specific IgE results need careful interpretation. A few situations can produce numbers that do not match your true clinical picture:

  • Sensitization without symptoms: a positive result means your immune system has made the antibody, not that you will react when you eat tuna. Many sensitized people tolerate the food without issue.
  • Cross-reactivity from other allergens: parvalbumin is structurally similar across many fish and even some non-fish species, so an elevated tuna parvalbumin IgE may reflect exposure to a different parvalbumin-containing food.
  • Allergy to a tuna protein other than parvalbumin: if you react to tuna but the parvalbumin component is negative, your reaction may involve a different protein such as enolase or aldolase, which require separate testing.
  • Anti-IgE therapy: medications like omalizumab specifically lower free IgE levels by design. If you are on this treatment, your specific IgE result may not reflect your underlying sensitization.

Deciding What to Do With an Unexpected Result

A positive Thu a 1 IgE result on its own is not a diagnosis of tuna allergy. The next step depends on your history. If you have eaten tuna recently without symptoms, a positive result likely reflects sensitization without clinical allergy. If you have had a reaction after fish, a positive result supports that history but should be followed up with an allergist.

The most informative companion tests are IgE to other fish components, especially other fish parvalbumins, to map your full pattern of fish sensitization. A skin prick test with fresh fish, a basophil activation test, or a supervised oral food challenge may be used to determine actual reactivity. The oral food challenge remains the most definitive way to determine whether you can safely eat tuna, but it should always be performed in a medical setting. A board-certified allergist is the right specialist to coordinate this workup.

Frequently Asked Questions

References

16 studies
  1. Kuehn a, Hilger C, Lehners-weber C, Codreanu-morel F, Morisset M, Metz-favre C, Pauli G, Blay F, Revets D, Muller C, Vogel L, Vieths S, Hentges FClinical & Experimental Allergy2013
  2. James JM, Helm RM, Burks a, Lehrer SBAnnals of Allergy, Asthma & Immunology1997
  3. Bernhisel-broadbent J, Strause D, Sampson HAJournal of Allergy and Clinical Immunology1992
  4. Taki AC, Ruethers T, Nugraha R, Karnaneedi S, Williamson NA, Nie S, Kamath SD, Lopata ALAllergy2023
  5. Schoos a, Bullens D, Chawes B, Costa J, De Vlieger L, Dunngalvin a, Epstein M, Garssen J, Hilger C, Knipping K, Kuehn a, Mijakoski D, Munblit D, Nekliudov NA, Ozdemir C, Patient K, Peroni D, Stoleski S, Stylianou E, Tukalj M, Verhoeckx K, Zidarn M, Van De Veen WFrontiers in Immunology2020